Regulation of Fli1 gene expression in lupus

狼疮中 Fli1 基因表达的调控

基本信息

项目摘要

DESCRIPTION (provided by applicant): Systemic lupus erythematosus (SLE) is an increasingly prevalent systemic autoimmune disease affecting the joints, muscles, heart, lungs, blood, kidneys, skin and the central nervous system. Renal disease (lupus nephritis) is a common manifestation affecting up to two-thirds of lupus patients and is a major cause of morbidity and mortality. The lupus prone mouse models MRL/lpr and NZM 2410 develop an early onset autoimmune disease displaying a pathogenesis similar to that observed in human SLE with most mice dying of renal failure. Interestingly, when the transcription factor Fli1 is over-expressed in normal, healthy mice, the mice develop an autoimmune kidney disease similar to that observed in lupus prone mouse models. Subsequently, Fli1 was shown to be over-expressed in the splenic T cells of the lupus prone NZB/NZW f1 mouse strain, the spleen of lupus prone MRL/lpr mice, and lymphocytes of SLE patients. Furthermore, genetically lowering the levels of Fli1 in MRL/lpr mice by 50% significantly decreased autoantibody production, improved kidney disease and prolonged survival. Together, these studies strongly suggest that dysregulation and resulting over-expression of Fli1 plays a role in the pathogenesis of lupus. We hypothesize that the over-expression of Fli1 in lupus is a key event in the pathogenesis of lupus resulting from dysregulation of Fli1 gene transcription. To address our hypothesis we have proposed three aims. In specific aim 1 we propose to determine specifically which lymphocyte subsets in lupus prone mice over-express Fli1 compared to healthy, disease free controls. In addition we will analyze the rate of transcription and the message stability of Fli1 in lymphocyte subsets that over-express Fli1 in lupus prone mice compared to control mice. In specific aim 2 we propose to determine what cis-regulatory elements within the Fli1 promoter region are necessary for expression in control lymphocytes and what elements are involved in the over-expression in lymphocytes from lupus prone mice. For specific aim 3, we propose to identify transcription factors that bind to cis-regulatory elements in the Fli1 promoter in control lymphocytes and "disease" lymphocytes. The studies proposed in this application will further the understanding of the role of Fli1 in lupus and the molecular mechanisms involved in disease expression.
描述(由申请人提供): 全身性红斑狼疮(SLE)是一种越来越普遍的全身性自身免疫性疾病,影响关节,肌肉,心脏,肺,血液,肾脏,肾脏,皮肤和中枢神经系统。肾脏疾病(狼疮肾炎)是一种普遍的表现,影响了多达三分之二的狼疮患者,并且是发病率和死亡率的主要原因。狼疮小鼠模型MRL/LPR和NZM 2410产生了一种早期发作自身免疫性疾病,其发病机理与大多数死于肾衰竭的小鼠在人SLE中相似。有趣的是,当转录因子FLI1在正常,健康小鼠中过表达时,小鼠会形成一种自身免疫性肾脏疾病,类似于狼疮俯卧小鼠模型中的自身免疫性肾脏疾病。随后,在狼疮容易发生NZB/NZB/NZW F1小鼠菌株的脾脏T细胞中,FLI1被表达过表达,狼疮pro鼠MRL/LPR小鼠的脾脏和SLE患者的淋巴细胞。此外,从遗传上将MRL/LPR小鼠的FLI1水平降低了50%,可显着降低自身抗体的产生,改善肾脏疾病和长期生存率。总之,这些研究强烈表明,FLI1的失调和导致的过表达在狼疮的发病机理中起作用。我们假设狼疮中Fli1的过表达是狼疮发病机理的关键事件,这是由于FLI1基因转录失调引起的。为了解决我们的假设,我们提出了三个目标。在特定的目标1中,我们建议特定确定狼疮小鼠中哪些淋巴细胞亚群过表达FLI1与健康的无疾病对照相比。此外,我们将分析与对照小鼠相比,在狼疮小鼠中过表达FLI1的淋巴细胞子集中FLI1的转录速率和消息稳定性。在特定的目标2中,我们建议确定FLI1启动子区域内哪些顺式调节元件对于对照淋巴细胞的表达以及来自狼疮小鼠的淋巴细胞过表达涉及哪些元素。对于特定目标3,我们建议鉴定对照淋巴细胞和“疾病”淋巴细胞中FLI1启动子中与顺式调节元件结合的转录因子。本应用中提出的研究将进一步了解FLI1在狼疮中的作用以及涉及疾病表达的分子机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

TAMMY (TAMARA) NO...的其他基金

The role of Fli1 in T cell function and the pathogenesis of lupus
Fli1在T细胞功能和狼疮发病机制中的作用
  • 批准号:
    7685574
    7685574
  • 财政年份:
    2009
  • 资助金额:
    $ 11.74万
    $ 11.74万
  • 项目类别:
The role of Fli1 in T cell function and the pathogenesis of lupus
Fli1在T细胞功能和狼疮发病机制中的作用
  • 批准号:
    7784496
    7784496
  • 财政年份:
    2009
  • 资助金额:
    $ 11.74万
    $ 11.74万
  • 项目类别:
The role of Fli1 in T cell function and the pathogenesis of lupus
Fli1在T细胞功能和狼疮发病机制中的作用
  • 批准号:
    8195562
    8195562
  • 财政年份:
    2009
  • 资助金额:
    $ 11.74万
    $ 11.74万
  • 项目类别:
The role of Fli1 in the pathogenesis of lupus
Fli1在狼疮发病机制中的作用
  • 批准号:
    7393257
    7393257
  • 财政年份:
    2007
  • 资助金额:
    $ 11.74万
    $ 11.74万
  • 项目类别:
The role of Fli1 in the pathogenesis of lupus
Fli1在狼疮发病机制中的作用
  • 批准号:
    7194443
    7194443
  • 财政年份:
    2007
  • 资助金额:
    $ 11.74万
    $ 11.74万
  • 项目类别:
The role of Fli1 in the pathogenesis of lupus
Fli1在狼疮发病机制中的作用
  • 批准号:
    7590439
    7590439
  • 财政年份:
    2007
  • 资助金额:
    $ 11.74万
    $ 11.74万
  • 项目类别:
Regulation of Fli1 gene expression in lupus
狼疮中 Fli1 基因表达的调控
  • 批准号:
    7124734
    7124734
  • 财政年份:
    2005
  • 资助金额:
    $ 11.74万
    $ 11.74万
  • 项目类别:
Regulation of Fli1 gene expression in lupus
狼疮中 Fli1 基因表达的调控
  • 批准号:
    7694741
    7694741
  • 财政年份:
    2005
  • 资助金额:
    $ 11.74万
    $ 11.74万
  • 项目类别:
Regulation of Fli1 gene expression in lupus
狼疮中 Fli1 基因表达的调控
  • 批准号:
    6959337
    6959337
  • 财政年份:
    2005
  • 资助金额:
    $ 11.74万
    $ 11.74万
  • 项目类别:

相似国自然基金

海洋缺氧对持久性有机污染物入海后降解行为的影响
  • 批准号:
    42377396
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
氮磷的可获得性对拟柱孢藻水华毒性的影响和调控机制
  • 批准号:
    32371616
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
还原条件下铜基催化剂表面供-受电子作用表征及其对CO2电催化反应的影响
  • 批准号:
    22379027
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
CCT2分泌与内吞的机制及其对毒性蛋白聚集体传递的影响
  • 批准号:
    32300624
  • 批准年份:
    2023
  • 资助金额:
    10 万元
  • 项目类别:
    青年科学基金项目
在轨扰动影响下空间燃料电池系统的流动沸腾传质机理与抗扰控制研究
  • 批准号:
    52377215
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

Allogeneic BAFF Ligand Based CAR T-Cells as a Novel Therapy for Systemic Lupus Erythematous
基于同种异体 BAFF 配体的 CAR T 细胞作为系统性红斑狼疮的新疗法
  • 批准号:
    10761003
    10761003
  • 财政年份:
    2023
  • 资助金额:
    $ 11.74万
    $ 11.74万
  • 项目类别:
Aging and Oxidative Stress Influence Salivary Gland Disease in Sjogren's Syndrome
衰老和氧化应激对干燥综合征唾液腺疾病的影响
  • 批准号:
    10682148
    10682148
  • 财政年份:
    2023
  • 资助金额:
    $ 11.74万
    $ 11.74万
  • 项目类别:
Defining the autoimmune mechanisms driving human MOG antibody disease pathology
定义驱动人类 MOG 抗体疾病病理学的自身免疫机制
  • 批准号:
    10748070
    10748070
  • 财政年份:
    2023
  • 资助金额:
    $ 11.74万
    $ 11.74万
  • 项目类别:
Structural mechanisms of autoimmune diseases targeting cys-loop receptors
针对半胱氨酸环受体的自身免疫性疾病的结构机制
  • 批准号:
    10864719
    10864719
  • 财政年份:
    2023
  • 资助金额:
    $ 11.74万
    $ 11.74万
  • 项目类别:
Establishing Readiness of Dental Professionals in Practice-Based Research and Inter-Professional Care
使牙科专业人员做好基于实践的研究和跨专业护理的准备
  • 批准号:
    10755140
    10755140
  • 财政年份:
    2023
  • 资助金额:
    $ 11.74万
    $ 11.74万
  • 项目类别: